KUALA LUMPUR, Malaysia, Oct 5 (Bernama) — Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.
Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%. The test kit works by detecting the presence of the coronavirus nucleocapsid protein in saliva samples. Infants under the age of two are not recommended to use this test kit.
- OPEC+ To Raise Oil Output In December
- Hamas Handed Over Another Israeli Hostage’s Body To Red Cross
- Expo On China’s High-End Printing Technologies Held In Dubai
- Iraq Limits Agricultural Plan Due To Drought
- Yemen’s Houthis Declare General Mobilisation Amid Fears Of Possible Israeli Attack
- Indian Security Forces Killed Four Extremists In Manipur State
- U.S. Gov’t Shutdown Set To Break Record As Senate Again Fails To Pass Funding Bill
- Iraqi PM Says “National Consensus” Reached To Bring Weapons Under State Control
- Iraq, Türkiye Signed Executive Mechanism For Water Cooperation Agreement
- Over 127 Million Voters Registered For Bangladesh’s 13th General Election